Vancomycin-Associated Leukocytoclastic Vasculitis
Vancomycin is U.S. Food and Drug Administration (FDA) approved for treatment of serious infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or in individuals who have failed, cannot tolerate, or are allergic to other antibiotics. Very few cases of vancomycin-associated leukocytoc...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Case Reports in Infectious Diseases |
| Online Access: | http://dx.doi.org/10.1155/2011/356370 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832567998484840448 |
|---|---|
| author | Makhawadee Pongruangporn David J. Ritchie Dongsi Lu Jonas Marschall |
| author_facet | Makhawadee Pongruangporn David J. Ritchie Dongsi Lu Jonas Marschall |
| author_sort | Makhawadee Pongruangporn |
| collection | DOAJ |
| description | Vancomycin is U.S. Food and Drug Administration (FDA) approved for treatment of serious infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or in individuals who have failed, cannot tolerate, or are allergic to other antibiotics. Very few cases of vancomycin-associated leukocytoclastic vasculitis have been published. We report on a patient who developed pruritus and palpable purpura in both lower extremities after receiving six days of intravenous vancomycin. Skin biopsy revealed leukocytoclastic vasculitis. |
| format | Article |
| id | doaj-art-5a00c8b5542448fc92f24a1985cd0364 |
| institution | Kabale University |
| issn | 2090-6625 2090-6633 |
| language | English |
| publishDate | 2011-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Infectious Diseases |
| spelling | doaj-art-5a00c8b5542448fc92f24a1985cd03642025-02-03T00:59:53ZengWileyCase Reports in Infectious Diseases2090-66252090-66332011-01-01201110.1155/2011/356370356370Vancomycin-Associated Leukocytoclastic VasculitisMakhawadee Pongruangporn0David J. Ritchie1Dongsi Lu2Jonas Marschall3Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO 63110, USAPharmacy Practice Division, Department of Pharmacy and St. Louis College of Pharmacy, Barnes-Jewish Hospital, MO 63110, USADepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USADivision of Infectious Diseases, Washington University School of Medicine, St. Louis, MO 63110, USAVancomycin is U.S. Food and Drug Administration (FDA) approved for treatment of serious infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or in individuals who have failed, cannot tolerate, or are allergic to other antibiotics. Very few cases of vancomycin-associated leukocytoclastic vasculitis have been published. We report on a patient who developed pruritus and palpable purpura in both lower extremities after receiving six days of intravenous vancomycin. Skin biopsy revealed leukocytoclastic vasculitis.http://dx.doi.org/10.1155/2011/356370 |
| spellingShingle | Makhawadee Pongruangporn David J. Ritchie Dongsi Lu Jonas Marschall Vancomycin-Associated Leukocytoclastic Vasculitis Case Reports in Infectious Diseases |
| title | Vancomycin-Associated Leukocytoclastic Vasculitis |
| title_full | Vancomycin-Associated Leukocytoclastic Vasculitis |
| title_fullStr | Vancomycin-Associated Leukocytoclastic Vasculitis |
| title_full_unstemmed | Vancomycin-Associated Leukocytoclastic Vasculitis |
| title_short | Vancomycin-Associated Leukocytoclastic Vasculitis |
| title_sort | vancomycin associated leukocytoclastic vasculitis |
| url | http://dx.doi.org/10.1155/2011/356370 |
| work_keys_str_mv | AT makhawadeepongruangporn vancomycinassociatedleukocytoclasticvasculitis AT davidjritchie vancomycinassociatedleukocytoclasticvasculitis AT dongsilu vancomycinassociatedleukocytoclasticvasculitis AT jonasmarschall vancomycinassociatedleukocytoclasticvasculitis |